|
Orthologous residues
|
|
EpoR (human): Y454‑p, EpoR (mouse): Y453‑p, EpoR (rat): Y453‑p
|
|
Characterization
|
|
Methods used to characterize site in vivo:
mutation of modification site, western blotting
|
|
Relevant cell lines - cell types - tissues:
BaF3 ('B lymphocyte, precursor'), gamma 2a (fibroblast)
|
|
Cellular systems studied:
cell lines
|
|
Species studied:
mouse
|
|
Upstream Regulation
|
|
Potential in vivo enzymes for site:
|
|
Type
|
Enzyme
|
Evidence
|
Notes
|
|
KINASE
|
JAK2 (human)
|
transfection of constitutively active enzyme, transfection of dominant-negative enzyme
|
|
|
|
Downstream Regulation
|
|
Effect of modification (function):
molecular association, regulation, receptor internalization, altered
|
|
Modification regulates interactions with:
|
|
Interacting molecule
|
Interacting domains
|
Effect
|
Consequences (function)
|
Consequences (process)
|
Detection assays
|
|
PIK3R1 (mouse)
|
|
Induces
|
|
|
co-immunoprecipitation
|
|
PIK3R2 (mouse)
|
|
Induces
|
|
|
co-immunoprecipitation
|
|
|
Comments:
required for optimal PIK3R1/2 binding
|
|
Associated Diseases
|
|
Diseases:
|
Alterations:
|
Comments:
|
|
PFCP
|
deletion of site
|
|
|